Earnings Call · Q1 FY2025·2025-05-13

Q1 25EPS +23.53%·Rev n/aQ4 24EPS +1.52%·Rev n/aQ3 24EPS +11.11%·Rev n/aQ2 24EPS -2.94%·Rev n/a⚠ consensus missing

Altimmune, Inc. ALT

Lee Roth — Investor Relations or Corporate Communications

Vipin Garg — Chief Executive Officer

Scott Harris — Chief Medical Officer

Greg Weaver — Chief Financial Officer

−4.2%1d on move date−4.8% vs SPY3d−3.8%5d−8.5%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ALT calls or request research access.

More ALT calls Browse calls Request research access